Perspectives of monoclonal antibodies in the acute leukaemias.
Hervé
P
P
BMT Unit and Regional Blood Center, Besançon, France.
Wijdenes
J
J
Racadot
E
E
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000912:Antibodies, Neoplasm / Q000627:therapeutic use*; D001853:Bone Marrow / Q000473:pathology; D016026:Bone Marrow Transplantation; D003165:Complement System Proteins / Q000276:immunology; D005544:Forecasting; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use; D007938:Leukemia / Q000276:immunology / Q000473:pathology / Q000601:surgery*; D008280:Magnetics; D008863:Microspheres; D014411:Neoplastic Stem Cells / Q000276:immunology; D011300:Preoperative Care / Q000379:methods*; D014182:Transplantation, Autologous
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000922:Immunotoxins; D003165:Complement System Proteins